QZL · Class II · 21 CFR 892.2052

FDA Product Code QZL: Post-ablation Tissue Response Prediction Software

A Post-ablation Tissue Response Prediction Software Is An Image Processing Device Intended To Aid Physicians With Adjunctive Information In Their Clinical Assessment Of The Ablation Zone Following A Tissue Ablation Procedure. This Device Uses Information Extracted From Medical Images Along With Other Clinical Data To Predict The Ablation Zone Post Treatment.

Leading manufacturers include Techsomed Medical Technologies , Ltd..

2
Total
1
Cleared
178d
Avg days
2023
Since
Stable submission activity - 1 submissions in the last 2 years
Review times improving: avg 88d recently vs 267d historically

FDA 510(k) Cleared Post-ablation Tissue Response Prediction Software Devices (Product Code QZL)

2 devices
1–2 of 2

About Product Code QZL - Regulatory Context

510(k) Submission Activity

2 total 510(k) submissions under product code QZL since 2023, with 1 receiving FDA clearance (average review time: 178 days).

Submission volume has remained relatively stable over the observed period, with 1 submissions in the last 24 months.

FDA Review Time

Recent submissions under QZL have taken an average of 88 days to reach a decision - down from 267 days historically, suggesting improved FDA processing for this classification.

QZL devices are reviewed by the Radiology panel. Browse all Radiology devices →